Alphabet’s X shares Amber EEG system to expand the quest for mental health biomarkers

Alphabet’s X details Project Amber, a quest for a sin­gle bio­mark­er for depres­sion that fell short of its goal (TechCrunch): Alphabet’s X (the Google-owner’s so-called “Moon­shot Fac­to­ry”) pub­lished a new blog post today about Project Amber, a project it’s been work­ing on over the past three years — the results of which it’s now making…

Read More

Mindstrong Health recruits slew of Silicon Valley talent

_______ Mind­strong Health Expands Exec­u­tive Team to Advance Tech­nol­o­gy for New Vir­tu­al Men­tal Health Care Mod­el (press release): “Mind­strong Health, a health­care inno­va­tion com­pa­ny ded­i­cat­ed to trans­form­ing men­tal health through inno­va­tions in dig­i­tal mea­sure­ment and vir­tu­al care mod­els, today announced the addi­tion of ten senior exec­u­tives to its lead­er­ship team includ­ing CEO Daniel Graf, who…

Read More

Mixed reactions on the development of digital biomarkers and growth of Mindstrong Health

___ (More on the pos­i­tive side, at MIT Tech­nol­o­gy Review) The smart­phone app that can tell you’re depressed before you know it your­self: “There are about 45 mil­lion peo­ple in the US alone with a men­tal ill­ness, and those ill­ness­es and their cours­es of treat­ment can vary tremen­dous­ly. But there is some­thing most of those people…

Read More

With two new funding mechanisms, The Chan Zuckerberg Initiative reaches out of neuroscience to expand its Neurodegeneration Challenge Network

___ RFA Now Open: CZI Neu­rode­gen­er­a­tion Chal­lenge Net­work (Chan Zucker­berg Ini­tia­tive release): “The Chan Zucker­berg Ini­tia­tive invites appli­ca­tions to join the CZI Neu­rode­gen­er­a­tion Chal­lenge Net­work, an inter­dis­ci­pli­nary col­lab­o­ra­tive ini­tia­tive to increase under­stand­ing of the fun­da­men­tal biol­o­gy of neu­rode­gen­er­a­tive dis­or­ders. Appli­ca­tions are being accept­ed for two fund­ing mechanisms:

Read More

E‑Newsletter: Neuroimaging + machine learning can predict, with 96% accuracy, whether high-risk 6‑month-old babies will develop autism spectrum disorder (ASD) by age 2

_____ Time for Sharp­Brains’ June e‑newsletter, fea­tur­ing fas­ci­nat­ing sci­en­tif­ic find­ings, promis­ing assess­ments, ther­a­pies and brain health mon­i­tor­ing tools…and some fun opti­cal illu­sions :-) New research Study com­bines neu­roimag­ing with machine learn­ing to pre­dict, with 96% accu­ra­cy, whether high-risk 6‑month-old babies will devel­op autism spec­trum dis­or­der (ASD) by age 2 Cog­ni­tive Train­ing or Gingko Bilo­ba to pre­vent cog­ni­tive decline and…

Read More

Study combines neuroimaging with machine learning to predict, with 96% accuracy, whether high-risk 6‑month-old babies will develop autism spectrum disorder (ASD) by age 2

— A Sin­gle Brain Scan Has Been Used to Accu­rate­ly Pre­dict Autism at Just 6 Months Old (Sci­ence alert) “Researchers have used brain scans and arti­fi­cial intel­li­gence to spot dif­fer­ences in how key areas of infant brains syn­chro­nise, allow­ing them to accu­rate­ly pre­dict which babies would devel­op autism spec­trum dis­or­der (ASD) as a toddler…The research, led…

Read More